SCHEMBL7902256

SCHEMBL7902256

CC(C)=CCN1[C@H](C)c2cccc([N+](=O)[O-])c2NC[C@@H]1C

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.35
CYP2D6 P10635 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
CYP3A4 P08684 1/20 0.35
MAPT P10636 3/20 0.33
NR4A1 P22736 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ERN1 O75460 1/20 0.33
KDM4E B2RXH2 1/20 0.33
KMT2A Q03164 4/20 0.33
MAPK1 P28482 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
PRCP P42785 1/20 0.33
MEN1 O00255 3/20 0.32
ALDH1A1 P00352 3/20 0.32
POLB P06746 2/20 0.32
RAB9A P51151 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7902260 1.00 CYP1A2 (0.35) CYP1A2CYP2D6CYP2C9CYP2C19CYP3A4
SCHEMBL9436772 0.78 CHRNB2 (0.34) CYP1A2CYP2D6CYP2C9CYP2C19CYP3A4
SCHEMBL9535908 0.78 CHRNB2 (0.34) CYP1A2CYP2D6CYP2C9CYP2C19CYP3A4
SCHEMBL7902272 0.70 KDM4E (0.32) KDM4EALDH1A1POLBTDP1
SCHEMBL8844480 0.70
SCHEMBL27657163 0.70 SMN1; SMN2 (0.45) CYP1A2CYP2D6CYP2C9CYP2C19CYP3A4
SCHEMBL9388439 0.68 ACHE (0.36) CYP1A2CYP2C9CYP2C19NR4A1KMT2A
SCHEMBL7904443 0.68
SCHEMBL7904440 0.68
SCHEMBL7903560 0.67 TDP1 (0.39) MAPTNR4A1SMN1; SMN2KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6201119-B1 2,3,4,5-TETRAHYDRO-1H-1,4-BENZODIAZEPIN-9-AMINE COMPOUNDS USEFUL AS INTERMEDIATES TO ANTIVIRALS JANSSEN PHARMACEUTICA N.V. (BE) 2001-03-13 US disclosed
US-5371079-A Administering to inhibit replication of HIV-1 in human cells JANSSEN PHARMACEUTICA N.V. (BE) 1994-12-06 US disclosed
US-5270464-A Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones JANSSEN PHARMACEUTICA N.V. (BE) 1993-12-14 US disclosed
EP-0491751-A1 ANTIVIRAL TETRAHYDROIMIDAZO 1,4]BENZODIAZEPINES JANSSEN PHARMACEUTICA N.V. (BE) 1992-07-01 EP disclosed
WO-1991004255-A1 ANTIVIRAL TETRAHYDROIMIDAZO[1,4]BENZODIAZEPINES JANSSEN PHARMACEUTICA N.V. (BE) 1991-04-04 WO disclosed